Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $568,864 | $627,104 | $410,674 | $427,468 |
| - Cash | $107,225 | $178,536 | $250,013 | $383,275 |
| + Debt | $118,387 | $121,894 | $117,160 | $114,887 |
| Enterprise Value | $580,026 | $570,462 | $277,821 | $159,080 |
| Revenue | $13,267 | $9,914 | $8,507 | $8,155 |
| % Growth | 33.8% | 16.5% | 4.3% | – |
| Gross Profit | $13,351 | $9,187 | $7,806 | $7,208 |
| % Margin | 100.6% | 92.7% | 91.8% | 88.4% |
| EBITDA | -$59,835 | -$83,334 | -$61,251 | -$73,251 |
| % Margin | -451% | -840.6% | -720% | -898.2% |
| Net Income | -$60,669 | -$83,426 | -$60,233 | -$73,243 |
| % Margin | -457.3% | -841.5% | -708% | -898.1% |
| EPS Diluted | -0.28 | -0.39 | -0.39 | -0.48 |
| % Growth | 28.2% | 0% | 18.7% | – |
| Operating Cash Flow | – | -$71,498 | -$130,484 | $8,775 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$71,498 | -$130,484 | $8,775 |